Pubertal exposure to dietary advanced glycation end products disrupts ductal morphogenesis and induces atypical hyperplasia in the mammary gland.
Advanced glycation end products
Diet
Mammary gland development
Microenvironment
Puberty
RAGE
Journal
Breast cancer research : BCR
ISSN: 1465-542X
Titre abrégé: Breast Cancer Res
Pays: England
ID NLM: 100927353
Informations de publication
Date de publication:
06 10 2023
06 10 2023
Historique:
received:
27
04
2023
accepted:
18
09
2023
medline:
1
11
2023
pubmed:
7
10
2023
entrez:
6
10
2023
Statut:
epublish
Résumé
Advanced glycation end products (AGEs) are reactive metabolites intrinsically linked with modern dietary patterns. Processed foods, and those high in sugar, protein and fat, often contain high levels of AGEs. Increased AGE levels are associated with increased breast cancer risk, however their significance has been largely overlooked due to a lack of direct cause-and-effect relationship. To address this knowledge gap, FVB/n mice were fed regular, low AGE, and high AGE diets from 3 weeks of age and mammary glands harvested during puberty (7 weeks) or adulthood (12 weeks and 7 months) to determine the effects upon mammary gland development. At endpoint mammary glands were harvested and assessed histologically (n ≥ 4). Immunohistochemistry and immunofluorescence were used to assess cellular proliferation and stromal fibroblast and macrophage recruitment. The Kruskal-Wallis test were used to compare continuous outcomes among groups. Mammary epithelial cell migration and invasion in response to AGE-mediated fibroblast activation was determined in two-compartment co-culture models. In vitro experiments were performed in triplicate. The nonparametric Wilcoxon rank sum test was used to compare differences between groups. Histological analysis revealed the high AGE diet delayed ductal elongation, increased primary branching, as well as increased terminal end bud number and size. The high AGE diet also led to increased recruitment and proliferation of stromal cells to abnormal structures that persisted into adulthood. Atypical hyperplasia was observed in the high AGE fed mice. Ex vivo fibroblasts from mice fed dietary-AGEs retain an activated phenotype and promoted epithelial migration and invasion of non-transformed immortalized and tumor-derived mammary epithelial cells. Mechanistically, we found that the receptor for AGE (RAGE) is required for AGE-mediated increases in epithelial cell migration and invasion. We observed a disruption in mammary gland development when mice were fed a diet high in AGEs. Further, both epithelial and stromal cell populations were impacted by the high AGE diet in the mammary gland. Educational, interventional, and pharmacological strategies to reduce AGEs associated with diet may be viewed as novel disease preventive and/or therapeutic initiatives during puberty.
Sections du résumé
BACKGROUND
Advanced glycation end products (AGEs) are reactive metabolites intrinsically linked with modern dietary patterns. Processed foods, and those high in sugar, protein and fat, often contain high levels of AGEs. Increased AGE levels are associated with increased breast cancer risk, however their significance has been largely overlooked due to a lack of direct cause-and-effect relationship.
METHODS
To address this knowledge gap, FVB/n mice were fed regular, low AGE, and high AGE diets from 3 weeks of age and mammary glands harvested during puberty (7 weeks) or adulthood (12 weeks and 7 months) to determine the effects upon mammary gland development. At endpoint mammary glands were harvested and assessed histologically (n ≥ 4). Immunohistochemistry and immunofluorescence were used to assess cellular proliferation and stromal fibroblast and macrophage recruitment. The Kruskal-Wallis test were used to compare continuous outcomes among groups. Mammary epithelial cell migration and invasion in response to AGE-mediated fibroblast activation was determined in two-compartment co-culture models. In vitro experiments were performed in triplicate. The nonparametric Wilcoxon rank sum test was used to compare differences between groups.
RESULTS
Histological analysis revealed the high AGE diet delayed ductal elongation, increased primary branching, as well as increased terminal end bud number and size. The high AGE diet also led to increased recruitment and proliferation of stromal cells to abnormal structures that persisted into adulthood. Atypical hyperplasia was observed in the high AGE fed mice. Ex vivo fibroblasts from mice fed dietary-AGEs retain an activated phenotype and promoted epithelial migration and invasion of non-transformed immortalized and tumor-derived mammary epithelial cells. Mechanistically, we found that the receptor for AGE (RAGE) is required for AGE-mediated increases in epithelial cell migration and invasion.
CONCLUSIONS
We observed a disruption in mammary gland development when mice were fed a diet high in AGEs. Further, both epithelial and stromal cell populations were impacted by the high AGE diet in the mammary gland. Educational, interventional, and pharmacological strategies to reduce AGEs associated with diet may be viewed as novel disease preventive and/or therapeutic initiatives during puberty.
Identifiants
pubmed: 37803429
doi: 10.1186/s13058-023-01714-4
pii: 10.1186/s13058-023-01714-4
pmc: PMC10559657
doi:
Substances chimiques
Dietary Advanced Glycation End Products
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
118Subventions
Organisme : NCI NIH HHS
ID : R01 CA245143
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA138313
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA046934
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA258139
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA259415
Pays : United States
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
J Nutr. 2006 Oct;136(10):2697S-9S
pubmed: 16988155
BMC Public Health. 2019 Dec 2;19(1):1606
pubmed: 31791293
J Food Sci Technol. 2015 Dec;52(12):7561-76
pubmed: 26604334
Biomark Res. 2020 Nov 11;8(1):64
pubmed: 33292666
J Adolesc Health. 2016 Oct;59(4S):S61-S75
pubmed: 27664597
J Mammary Gland Biol Neoplasia. 2017 Jun;22(2):93-108
pubmed: 28168376
Breast Cancer Res. 2015 Nov 02;17(1):138
pubmed: 26526858
Transl Oncol. 2022 Mar;17:101350
pubmed: 35091340
Neoplasia. 2004 Jan-Feb;6(1):1-6
pubmed: 15068665
EMBO J. 1988 Jul;7(7):2089-95
pubmed: 3416834
Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):567-71
pubmed: 7549816
Breast Cancer Res Treat. 2019 Feb;173(3):559-571
pubmed: 30368741
Development. 2014 Apr;141(7):1562-71
pubmed: 24598160
Biochemistry. 2014 May 27;53(20):3327-35
pubmed: 24824951
Patient Intell. 2011 May 12;2011(3):29-38
pubmed: 23180975
Nutrients. 2019 Feb 13;11(2):
pubmed: 30781793
J Mammary Gland Biol Neoplasia. 2000 Apr;5(2):227-41
pubmed: 11149575
Wiley Interdiscip Rev Dev Biol. 2012 Jul-Aug;1(4):533-57
pubmed: 22844349
Cancer Res. 2015 May 15;75(10):1925-9
pubmed: 25920350
Compr Rev Food Sci Food Saf. 2020 Sep;19(5):2559-2587
pubmed: 33336972
Mol Med. 2018 Nov 23;24(1):59
pubmed: 30470170
J Clin Diagn Res. 2013 Nov;7(11):2537-40
pubmed: 24392394
J Agric Food Chem. 2018 Feb 14;66(6):1325-1329
pubmed: 29378411
Nat Med. 2008 May;14(5):518-27
pubmed: 18438415
J Carcinog. 2013 Oct 09;12:19
pubmed: 24227994
Cell Metab. 2018 Sep 4;28(3):337-352
pubmed: 30184484
Toxicol Pathol. 2008 Apr;36(3):375-84
pubmed: 18441260
Nature. 2014 Nov 20;515(7527):355-64
pubmed: 25409824
J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):181-91
pubmed: 19404726
Cancer Epidemiol Biomarkers Prev. 2021 Dec;30(12):2217-2226
pubmed: 34583965
J Biol Chem. 1992 Jul 25;267(21):14998-5004
pubmed: 1378843
Cancer Prev Res (Phila). 2020 Jul;13(7):601-610
pubmed: 32169887
PLoS One. 2012;7(4):e35143
pubmed: 22496902
Semin Cancer Biol. 2014 Apr;25:61-8
pubmed: 24560651
Annu Rev Public Health. 2016;37:33-46
pubmed: 26789387
Clin Exp Metastasis. 2005;22(1):47-59
pubmed: 16132578
J Clin Invest. 2004 Jun;113(11):1641-50
pubmed: 15173891
J Am Diet Assoc. 2010 Jun;110(6):911-16.e12
pubmed: 20497781
N Engl J Med. 2015 Jan 1;372(1):78-89
pubmed: 25551530
Nutrients. 2016 Nov 04;8(11):
pubmed: 27827899
Adv Cancer Res. 2017;133:1-22
pubmed: 28052818
Adv Cancer Res. 2020;146:57-82
pubmed: 32241392
Diabetes. 2003 Jun;52(6):1441-8
pubmed: 12765955
Crit Rev Food Sci Nutr. 2020;60(20):3475-3491
pubmed: 31760755
Nature. 1983 Jun 30;303(5920):767-70
pubmed: 6866078
Curr Med Chem. 2007;14(15):1653-71
pubmed: 17584071
Cell Mol Life Sci. 2007 Dec;64(24):3159-84
pubmed: 17955178
Front Genet. 2017 Dec 05;8:187
pubmed: 29259621
Ann N Y Acad Sci. 2005 Jun;1043:461-6
pubmed: 16037267
Diabetes. 2003 Nov;52(11):2805-13
pubmed: 14578300
Cancer. 2020 Jun 1;126(11):2648-2657
pubmed: 32097496
Breast Cancer Res. 2013;15(4):R70
pubmed: 23971998